Meta-Analysis of Trials of Partial Breast Irradiation
Abstract
PURPOSE
Partial breast irradiation (PBI) is the delivery of radiotherapy (RT) limited to the tumor bed following breast conserving surgery (BCS). The results of recent trials of PBI compared to whole breast irradiation (WBI) have suggested conflicting results with respect to local control and toxicity. The purpose of this meta-analysis was to assess effectiveness of PBI and to compare the different techniques.
METHODS
A meta-analysis of aggregate data from published randomized trials was performed to examine the effectiveness of PBI compared to WBI in patients with invasive breast cancer and ductal carcinoma in situ. Relevant data were extracted. The primary outcome was any ipsilateral breast event (invasive or non-invasive). Secondary outcomes included acute and late toxicity. The results of randomized trials were pooled using a fixed effects model and the inverse variance method.
RESULTS
Fifteen trials involving 16,474 patients were identified. The majority of enrolled patients were > 60 years of age and had T1N0 grade I-II, disease treated with endocrine therapy. The percent of ipsilateral breast events was higher in patients treated with PBI compared to WBI [5.0% vs. 2.8%, risk ratio (RR)=1.72, 95% confidence interval (CI) 1.47-2.03]. Heterogeneity (p=0.0002) was observed between the 4 PBI techniques: external beam RT without CT planning [risk ratio (RR)=2.06, 95% CI 1.36-3.12]; brachytherapy (RR=1.21, 95% CI 0.65-2.25); intraoperative RT (RR=2.79, 95% CI 2.08-3.73); and…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 16,474 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.